Cargando…

HEXIM1 controls P-TEFb processing and regulates drug sensitivity in triple-negative breast cancer

The positive transcription elongation factor b (P-TEFb), composed of CDK9 and cyclin T, stimulates transcriptional elongation by RNA polymerase (Pol) II and regulates cell growth and differentiation. Recently, we demonstrated that P-TEFb also controls the expression of EMT regulators to promote brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Hengyi, Zhu, Qingwei, Lu, Huasong, Chang, Amanda, Gao, Carol, Zhou, Qiang, Luo, Kunxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Cell Biology 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525814/ https://www.ncbi.nlm.nih.gov/pubmed/32520633 http://dx.doi.org/10.1091/mbc.E19-12-0704

Ejemplares similares

LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis
por: Ji, Xiaodan, et al.
Publicado: (2014)

PKC phosphorylates HEXIM1 and regulates P-TEFb activity
por: Fujinaga, Koh, et al.
Publicado: (2012)

Brd4 and HEXIM1: Multiple Roles in P-TEFb Regulation and Cancer
por: Chen, Ruichuan, et al.
Publicado: (2014)

Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription
por: Barboric, Matjaz, et al.
Publicado: (2007)

Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR
por: Sedore, Stanley C., et al.
Publicado: (2007)

HEXIM1 Diffusion in the Nucleus Is Regulated by Its Interactions with Both 7SK and P-TEFb
por: Furlan, Alessandro, et al.
Publicado: (2019)

Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb
por: Blazek, Dalibor, et al.
Publicado: (2005)

Acute hypoxia affects P-TEFb through HDAC3 and HEXIM1-dependent mechanism to promote gene-specific transcriptional repression
por: Safronova, Olga S., et al.
Publicado: (2014)

A Cyclin T1 point mutation that abolishes positive transcription elongation factor (P-TEFb) binding to Hexim1 and HIV tat
por: Verstraete, Nina, et al.
Publicado: (2014)

HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription
por: Contreras, Xavier, et al.
Publicado: (2007)

Tip110 Expression Facilitates the Release of HEXIM1 and pTEFb from the 7SK Ribonucleoprotein Complex Involving Regulation of the Intracellular Redox Level
por: Liu, Ying, et al.
Publicado: (2021)

LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated
por: Krueger, Brian J., et al.
Publicado: (2008)

The Mechanism of Release of P-TEFb and HEXIM1 from the 7SK snRNP by Viral and Cellular Activators Includes a Conformational Change in 7SK
por: Krueger, Brian J., et al.
Publicado: (2010)

Erratum to “Tip110 expression facilitates the release of HEXIM1 and pTEFb from the 7SK ribonucleoprotein complex involving regulation of the intracellular redox level”
por: Liu, Ying, et al.
Publicado: (2023)

AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoter
por: Schulze-Gahmen, Ursula, et al.
Publicado: (2014)

Inhibition of Tat activity by the HEXIM1 protein
por: Fraldi, Alessandro, et al.
Publicado: (2005)

HEXIM1-Tat chimera inhibits HIV-1 replication
por: Leoz, Marie, et al.
Publicado: (2018)

HEXIM1 is a critical determinant of the response to tamoxifen
por: Ketchart, Wannarasmi, et al.
Publicado: (2011)

Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cells
por: Huang, Min, et al.
Publicado: (2016)

P-TEFb- the final frontier
por: Kohoutek, Jiri
Publicado: (2009)

P‐TEFb goes viral
por: Zaborowska, Justyna, et al.
Publicado: (2015)

Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy
por: Neo, Shu Hui, et al.
Publicado: (2015)

HEXIM1 Induces Differentiation of Human Pluripotent Stem Cells
por: Ding, Vanessa, et al.
Publicado: (2013)

HEXIM1, a New Player in the p53 Pathway
por: Lew, Qiao Jing, et al.
Publicado: (2013)

Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells
por: Han, Liping, et al.
Publicado: (2017)

Megakaryocytic irreversible P-TEFb activation
por: Elagib, Kamaleldin E, et al.
Publicado: (2014)

Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex
por: Schulze-Gahmen, Ursula, et al.
Publicado: (2016)

Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis
por: Ketchart, Wannarasmi, et al.
Publicado: (2012)

EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours
por: Toosi, Behzad M., et al.
Publicado: (2018)

P-TEFb as A Promising Therapeutic Target
por: Fujinaga, Koh
Publicado: (2020)

Drug Repurposing for Triple-Negative Breast Cancer
por: Ávalos-Moreno, Marta, et al.
Publicado: (2020)

HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland
por: Ogba, Ndiya, et al.
Publicado: (2010)

The Drosophila 7SK snRNP and the essential role of dHEXIM in development
por: Nguyen, Duy, et al.
Publicado: (2012)

Functional Interaction between HEXIM and Hedgehog Signaling during Drosophila Wing Development
por: Nguyen, Duy, et al.
Publicado: (2016)

Structural transitions in the RNA 7SK 5′ hairpin and their effect on HEXIM binding
por: Röder, Konstantin, et al.
Publicado: (2020)

Non-epigenetic induction of HEXIM1 by DNMT1 inhibitors and functional relevance
por: Sharma, Vikas, et al.
Publicado: (2020)

SARS-CoV-2 down-regulates ACE2 through lysosomal degradation
por: Lu, Yi, et al.
Publicado: (2022)

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer
por: Doddapaneni, Ravi, et al.
Publicado: (2017)

Genomic Index of Sensitivity to Chemotherapy for Triple Negative Breast Cancer
por: C, Ahammad Sameer, et al.
Publicado: (2023)

Repurposing of drugs for triple negative breast cancer: an overview
por: Spini, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jjrnfce24v836s15nts144vmul